Capitainer News

Capitainer and Life Genomics Sign Partnership for Self-sampling Diagnostics Implementation

Press release | March 2024

Capitainer, a leading Swedish medtech company specializing in advanced self-sampling solutions, has signed a cooperation agr […]

Capitainer Announces Strategic Appointments to Board of Directors

Press release | March 2024

Capitainer announces the appointments of Louise Warme and Andreas Lindblom to its board of directors. These appointments com […]

Capitainer Secures SEK 30 Million Investment from We Venture Capital to Expand and Innovate in Self-Sampling Solutions

Press release | February 2024

Stockholm, February 15, 2024. Capitainer is proud to announce a significant financial investment of SEK 30 million from We V […]

Capitainer recruits application specialist to develop new test protocols and to support laboratories in their implementation of qDBS

Press release | January 2024

Capitainer, a leading Swedish medtech company specialising in advanced self-sampling solutions, has recruited Johan Olausson […]

Overcome the challenges of dried blood spot sampling with quantitative DBS technology – new editorial article in SelectScience

News | January 2024

In a new published editorial in SelectScience, based on an interview with the principal scientist of Capitainer, Donald Chac […]

Capitainer Opens New Microsampling Laboratory in Rhode Island, U.S.

Press release | January 2024

Capitainer is pleased to announce the opening of its new U.S. laboratory, miQro Lab Solutions, in Warwick, Rhode Island. Thi […]

Capitainer Secures Three US Patents for Innovative Plasma/Serum Separation Device

Press release | January 2024

Stockholm, January 11th 2024. Capitainer, a leading Swedish medtech innovator specializing in advanced self-sampling solutio […]

Capitainer and The Human Protein Atlas in focus in article in leading Swedish newspaper

News | November 2023

In a recent article in Dagens Industri, Sweden’s leading business newspaper, Capitainer’s shareholder Professor Mathias Uhlé […]

Capitainer’s products cornerstone of COVID-19 study by the Swedish Public Health Agency, published in The Lancet

Press release | October 2023

Stockholm, October 3rd 2023. An increased number of vaccine doses, administrated more frequently, reduces the mortality of C […]